MedPath

Feasibility and impact on quality of life of therapeutic fasting in people with Type 1 Diabetes Mellitus (T1DM)

Phase 1
Conditions
E10
Type 1 diabetes mellitus
Registration Number
DRKS00017504
Lead Sponsor
ehrstuhl für Medizintheorie, Integrative und Anthroposophische Medizin
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
30
Inclusion Criteria

T1DM diagnosis at least one year prior to the first day of fasting
Availability of a system for continuous glucose monitoring or Free Style libre
Age between 18 and 75 years
Duration of diabetes: > 1 year
Creatinine < 1,00 mg/dl
HbA1c: 5,6 - 8,0 mg/dl
Presence of signed declaration of consent for data acquisition, to fill in questionnaires and to take part in the fasting intervention of 9 days
Legal capacity

Exclusion Criteria

Acute psychiatric condition with need for treatment
Severe internal condition
Acute febrile illness
Renal insufficiency and other kidney diseases that need treatment or dialysis
pregnancy
lactation
Any addiction
Tumor disease
BMI < 21 (threat for anorexia)
Diabetes insipidus
application for occupational disability in process
Participation in another clinical or observation study within the last 4 weeks

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Ketoacidosis, hypoglycaemia, overall wellbeing (WHO 5), diabetes related problem areas (PAID)
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath